Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00005870
What this trial is testing

Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06974929
What this trial is testing

A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 80
Not applicableNo Longer AvailableNCT05941637
What this trial is testing

An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)

Who this might be right for
Clear Cell Kidney CancerKidney CancerKidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
Lynkcell Europe
Testing effectiveness (Phase 2)Ended earlyNCT03284957
What this trial is testing

Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer

Who this might be right for
Breast Cancer
Sanofi 136
Early research (Phase 1)WithdrawnNCT00118300
What this trial is testing

Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00740467
What this trial is testing

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Institut Paoli-Calmettes 50
Testing effectiveness (Phase 2)Study completedNCT00445198
What this trial is testing

A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies

Who this might be right for
Small Cell Lung CancerSmall Cell Lung Carcinoma
AbbVie (prior sponsor, Abbott) 86
Not applicableStudy completedNCT01507441
What this trial is testing

Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial

Who this might be right for
Leukemia
Children's Oncology Group 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04053322
What this trial is testing

Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.

Who this might be right for
ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancera Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
UNICANCER 172
Testing effectiveness (Phase 2)Looking for participantsNCT05451602
What this trial is testing

HEC169096 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Sunshine Lake Pharma Co., Ltd. 456
Testing effectiveness (Phase 2)UnknownNCT00057395
What this trial is testing

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Who this might be right for
Esophageal NeoplasmsHepatocellular CarcinomaColorectal Neoplasms+3 more
Aronex Pharmaceuticals 40
Not applicableLooking for participantsNCT04442334
What this trial is testing

The European NAFLD Registry

Who this might be right for
NAFLDNASHNASH - Nonalcoholic Steatohepatitis+9 more
Newcastle University 10,000
Not applicableStudy completedNCT01542333
What this trial is testing

Studying Biomarkers in Samples From Younger Patients With Wilms Tumor

Who this might be right for
Kidney Cancer
Children's Oncology Group 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05726864
What this trial is testing

ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerKRAS G12D+11 more
Elicio Therapeutics 158
Early research (Phase 1)Looking for participantsNCT06915753
What this trial is testing

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Who this might be right for
Metastatic Hepatocellular CarcinomaSolid TumorsSolid Tumor, Adult+8 more
Tyra Biosciences, Inc 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT05600894
What this trial is testing

Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic SyndromeMyelodysplastic Syndrome With Excess Blasts+2 more
National Cancer Institute (NCI) 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT06125522
What this trial is testing

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)

Who this might be right for
Breast Cancer
Pfizer 11
Not applicableStudy completedNCT03360695
What this trial is testing

Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer

Who this might be right for
CancerSevere Major DepressionSchizophrenia+5 more
Massachusetts General Hospital 185
Early research (Phase 1)Looking for participantsNCT07584226
What this trial is testing

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

Who this might be right for
Advanced NRAS-Mutant MelanomaAdvanced NRAS-Mutant Solid TumorsNRAS Mutation+8 more
Relay Therapeutics, Inc. 35
Early research (Phase 1)WithdrawnNCT02915172
What this trial is testing

Lenvatinib and Capecitabine in Patients With Advanced Malignancies

Who this might be right for
Advanced CancerMalignant Neoplasm of BreastMalignant Neoplasms of Bone and Articular Cartilage+11 more
M.D. Anderson Cancer Center
Next Page